Showing 101-110 of 9243 results for "".
- Maternal and Infant Skin Microbiomes Show Distinct but Connected Developmenthttps://practicaldermatology.com/news/maternal-and-infant-skin-microbiomes-show-distinct-but-connected-development/2488255/The skin microbiomes of mothers and their infants appear to be closely connected during early life, although infant microbial diversity follows its own developmental trajectory, according to a recent longitudinal study published in Experimental Dermatology. Researchers for the stu
- Medical Creators Produce Higher-Quality Alopecia Areata Content on Social Media: Studyhttps://practicaldermatology.com/news/medical-creators-produce-higher-quality-alopecia-areata-content-on-social-media/2488252/A cross-sectional study of alopecia areata content on 3 major Chinese social media platforms found that video quality, reliability, and adherence to clinical guidance varied substantially by platform and creator background. Investigators evaluated 111 high-engagement educational videos ide
- Hidradenitis Suppurativa Linked to Higher Cardiovascular Risk: Meta-Analysishttps://practicaldermatology.com/news/hidradenitis-suppurativa-linked-to-higher-cardiovascular-risk-meta-analysis/2488190/Hidradenitis suppurativa (HS) was associated with increased risk of multiple cardiovascular outcomes in a systematic review and meta-analysis encompassing 373,689 individuals with the chronic inflammatory skin disease. Cardiovascular Comorbidities and Hidradenitis Suppurativa
- INTerpath-001: Intismeran Plus Pembrolizumab Meets Dual Phase 3 Melanoma Endpointshttps://practicaldermatology.com/news/intismeran-plus-pembrolizumab-meets-dual-phase-3-melanoma-endpoints/2488176/Merck and Moderna reported positive topline results from the phase 3 INTerpath-001 trial evaluating intismeran autogene (V940; mRNA-4157) plus pembrolizumab (Keytruda) as adjuvant therapy for completely resected stage IIB-IV cutaneous melanoma. The individualized mRNA-based neoantigen ther
- Occupational Exposures Implicated in More Than Half of Chronic Hand Eczema Caseshttps://practicaldermatology.com/news/occupational-exposures-implicated-in-more-than-half-of-chronic-hand-eczema-cases/2488120/A new retrospective study of adults with chronic hand eczema (CHE) found allergic contact dermatitis (ACD) and occupational exposures were common, while most patients improved following diagnosis and treatment recommendations that included allergen avoidance. Investigators evaluated 76 adu
- Monophasic HA Shows Longer-Term Benefit in Nasolabial Fold Correctionhttps://practicaldermatology.com/news/monophasic-ha-shows-longer-term-benefit-in-nasolabial-fold-correction/2488118/A randomized study comparing 2 types of hyaluronic acid (HA) dermal fillers found similar early improvements in moderate-to-severe nasolabial folds (NLFs), with outcomes favoring monophasic HA at 36 weeks. Galinde et al conducted a randomized, controlled, double-blinded, intraindividual st
- GLP-1 Receptor Agonists Not Linked to Increased Melanoma Risk in T2Dhttps://practicaldermatology.com/news/glp-1-receptor-agonists-not-linked-to-increased-melanoma-risk-in-t2d/2488105/GLP-1 receptor agonist (GLP-1RA) therapy was not associated with an increased risk of melanoma among adults with type 2 diabetes (T2D) in a large target trial emulation published in Diabetes, Obesity and Metabolism. GLP-1RA Use and Skin Cancer Risk Investigators used TriN
- Treatment Sessions Linked to ABNOM Clearance in Laser Meta-Analysishttps://practicaldermatology.com/news/treatment-sessions-linked-to-abnom-clearance-in-laser-meta-analysis/2488080/Treatment session number was more strongly associated with clearance of acquired bilateral nevus of Ota-like macules (ABNOM) than whether patients received picosecond (PS) or Q-switched (QS) laser treatment, according to a new study. Published in Lasers in Medical Science, the ana
- Merz Aesthetics Announces FDA Clearance of Ultherapy PRIME for Knee Skin Laxityhttps://practicaldermatology.com/news/merz-aesthetics-announces-fda-clearance-of-ultherapy-prime-for-knee-skin-laxity/2488072/The US Food and Drug Administration (FDA) has cleared Ultherapy PRIME (Merz Aesthetics) to improve the appearance of skin laxity on the knees, according to an announcement from the company. Merz Aesthetics said the clearance makes Ultherapy PRIME the first energy-based aesthetic device wit
- Study: Reddit Upvotes May Not Reflect Quality of Rosacea Advicehttps://practicaldermatology.com/news/study-reddit-upvotes-may-not-reflect-quality-of-rosacea-advice/2488056/A study of Reddit’s r/Rosacea community examined what users discuss and whether engagement differed according to how closely recommendations aligned with National Rosacea Society (NRS) standard management options. Treatment Experiences Dominate Rosacea Discussions Investigators an